TRMK Stock Analysis: Trustmark | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 2.714m USD | 12M Return: 21% | US8984021027 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.0M
EPS Trend: 91.2%
Qual. Beats: 0
Rev. Trend: 74.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Trustmark Corporation (NASDAQ: TRMK) is a bank holding company for Trustmark National Bank, providing banking and financial solutions to individuals and corporate clients across the United States. Founded in 1889 and headquartered in Jackson, Mississippi, the company operates through two main segments: General Banking and Wealth Management. Its offerings span deposit products (checking, savings, money market accounts, certificates of deposit, and IRAs), treasury management, and a diverse loan portfolio covering commercial and industrial lending, commercial and owner-occupied real estate, construction and land development, and installment and real estate loans. Trustmark also provides mortgage banking services, trust and wealth management offerings for individuals, employee benefit plans, and foundations, as well as institutional custody, financial and estate planning, and retirement plan services. In addition, the company acts as an intermediary for loans and investments in low-income communities, a function typical of regional banks that operate under Community Reinvestment Act obligations.
As a mid-cap regional bank in the Financials sector, Trustmarks business model combines traditional interest-generating lending with fee-based revenue from wealth management and mortgage banking, allowing it to diversify income beyond net interest margin.
- Net interest margin compresses amid rising deposit costs
- Commercial real estate loan losses pressure credit quality
- Mortgage banking revenue softens on lower origination volumes
| Net Income: 234.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.38 > 1.0 |
| NWC/Revenue: 190.7% < 20% (prev -1.48k%; Δ 1.67k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 207.8m > Net Income 234.3m |
| Net Debt (-1.81b) to EBITDA (339.3m): -5.32 < 3 |
| Current Ratio: 7.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.7m) vs 12m ago -3.29% < -2% |
| Gross Margin: 67.02% > 18% (prev 64.29%; Δ 2.73% > 0.5%) |
| Asset Turnover: 6.25% > 50% (prev 5.42%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 0.82 > 6 (EBIT TTM 294.9m / Interest Expense TTM 359.9m) |
| A: 0.12 (Total Current Assets 2.61b - Total Current Liabilities 360.0m) / Total Assets 19.2b |
| B: 0.11 (Retained Earnings 2.13b / Total Assets 19.2b) |
| C: 0.02 (EBIT TTM 294.9m / Avg Total Assets 18.9b) |
| D: 0.13 (Book Value of Equity 2.14b / Total Liabilities 17.0b) |
| Altman-Z'' = 1.37 = BB |
As of September 11, 2026, the stock is trading at USD 47.45 with a total of 692,535 shares traded. Over the past week, the price has changed by +3.56%, over one month by +0.87%, over three months by +5.51% and over the past year by +21.02%.
Current recommended Stop Loss: 46.50 (which is 2% or 1.2 ATR below the current price).
Trustmark has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold TRMK.
- StrongBuy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 49.3 | 3.8% |
P/E Trailing = 11.8626
P/E Forward = 11.8906
P/S = 3.3298
P/B = 1.2483
P/EG = 2.2868
Revenue TTM = 1.18b USD
EBIT TTM = 294.9m USD
EBITDA TTM = 339.3m USD
Long Term Debt = 371.8m USD (from longTermDebt, last quarter)
Short Term Debt = 360.0m USD (from shortTermDebt, last quarter)
Debt = 806.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 37.1m
Net Debt = -1.81b USD (calculated: Debt 806.0m - CCE 2.61b)
Enterprise Value = 909.0m USD (2.71b + Debt 806.0m - CCE 2.61b)
Interest Coverage Ratio = 0.82 (Ebit TTM 294.9m / Interest Expense TTM 359.9m)
EV/FCF = 4.79x (Enterprise Value 909.0m / FCF TTM 189.7m)
FCF Yield = 20.87% (FCF TTM 189.7m / Enterprise Value 909.0m)
FCF Margin = 16.06% (FCF TTM 189.7m / Revenue TTM 1.18b)
Net Margin = 19.84% (Net Income TTM 234.3m / Revenue TTM 1.18b)
Gross Margin = 67.02% ((Revenue TTM 1.18b - Cost of Revenue TTM 389.4m) / Revenue TTM)
Gross Margin QoQ = 69.76% (prev 73.21%)
Tobins Q-Ratio = 0.05 (Enterprise Value 909.0m / Total Assets 19.2b)
Interest Expense / Debt = 44.65% (Interest Expense 359.9m / Debt 806.0m)
Taxrate = 20.56% (60.6m / 294.9m)
NOPAT = 234.3m (EBIT 294.9m * (1 - 20.56%))
Current Ratio = 7.25 (Total Current Assets 2.61b / Total Current Liabilities 360.0m)
Debt / Equity = 0.38 (Debt 806.0m / totalStockholderEquity, last quarter 2.14b)
Debt / EBITDA = -5.32 (Net Debt -1.81b / EBITDA 339.3m)
Debt / FCF = -9.52 (Net Debt -1.81b / FCF TTM 189.7m)
Total Stockholder Equity = 2.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.24% (Net Income 234.3m / Total Assets 19.2b)
RoE = 11.01% (Net Income TTM 234.3m / Total Stockholder Equity 2.13b)
RoCE = 11.80% (EBIT 294.9m / Capital Employed (Equity 2.13b + L.T.Debt 371.8m))
RoIC = 1.22% (NOPAT 234.3m / Invested Capital 19.1b)
WACC = 14.59% (E(2.71b)/V(3.52b) * Re(8.39%) + D(806.0m)/V(3.52b) * Rd(44.65%) * (1-Tc(0.21)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -89.65 | Cagr: -1.93%
[DCF] Terminal Value 53.58% ; FCFF base≈215.7m ; Y1≈189.1m ; Y5≈152.8m
[DCF] Fair Price = 52.03 (EV 1.22b - Net Debt -1.81b = Equity 3.03b / Shares 58.2m; r=14.59% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 91.20 | EPS CAGR: 16.03% | SUE: 0.0 | # QB: 0
Revenue Correlation: 74.04 | Revenue CAGR: 13.26% | SUE: 0.21 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.99 | Chg30d=-0.63% | Revisions=+0% | Analysts=6
EPS current Year (2026-12-31): EPS=3.94 | Chg30d=+0.72% | Revisions=+29% | GrowthEPS=+6.4% | GrowthRev=+4.6%
EPS next Year (2027-12-31): EPS=4.11 | Chg30d=+0.32% | Revisions=+12% | GrowthEPS=+4.4% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +19% (up=8, down=5)